With mpox cases mysteriously dwindling, scientists search for answers
PharmaVoice
DECEMBER 19, 2022
Was it a public health victory? Or did mpox ‘burn itself out?’ An epidemiologist weighs in.
PharmaVoice
DECEMBER 19, 2022
Was it a public health victory? Or did mpox ‘burn itself out?’ An epidemiologist weighs in.
PhRMA
DECEMBER 19, 2022
Recently, industry leaders, regulators, academics, data partners, and patient advocates gathered in Washington, D.C., to discuss using real-world data and real-world evidence for regulatory decision-making. The discussion explored emerging analytical methodologies to address the challenge of mitigating sources of bias and confounding variables that come up in nearly all sources of real-word data.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
DECEMBER 19, 2022
Successful clinical trials for digestive health treatments may soon yield approvals.
PharmaVoice
DECEMBER 19, 2022
A series of small successes showed promise for the future of blood cancer treatments, particularly in the arena of drug combinations.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
DECEMBER 19, 2022
The Medicare Part D Senior Savings Model — a CMS effort to test $35 copays for insulin — led to lowered total costs for beneficiaries.
Pharmacy Times
DECEMBER 19, 2022
Traditionally, endemic fungi are characterized by geographical distribution, however, disease-causing fungi may infect people beyond these havens.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
DECEMBER 19, 2022
An array of complications may arise associated with treatment of hemophilia A.
Fierce Healthcare
DECEMBER 19, 2022
2023 forecast: Amid dwindling COVID relief funds, rural hospitals face a 'fiscal cliff'. agliadkovskaya. Mon, 12/19/2022 - 14:42.
Pharmacy Times
DECEMBER 19, 2022
Investigators establish that audio and/or facial video features have been most analyzed by machine learning, followed by electroencephalography signals.
Fierce Healthcare
DECEMBER 19, 2022
2023 forecast: Providers embrace start of new requirements on health equity. rking. Mon, 12/19/2022 - 15:28.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
DECEMBER 19, 2022
Although physical activity and the practice of being present in the moment are associated with many benefits, analysis shows that neither led to measurable improvements in brain health.
Fierce Pharma
DECEMBER 19, 2022
Atara makes history with world-first nod for allogeneic T-cell therapy Ebvallo. fkansteiner. Mon, 12/19/2022 - 14:06.
Pharmacy Times
DECEMBER 19, 2022
Age was a contributing factor of chronic kidney disease and albuminuria in patients with type 1 and type 2 diabetes.
European Pharmaceutical Review
DECEMBER 19, 2022
A new £2.4 million Phase III trial will determine if ketamine-assisted therapy can help those with severe alcohol use disorder to stay off alcohol for longer. Led by the University of Exeter and funded by the Medical Research Council (MRC) and the National Institute for Health and Care Research (NIHR), “[t]his is the largest trial of its kind in the world and builds on our earlier, smaller positive trial,” stated Professor Anne Lingford-Hughes, Professor of Addiction Biology at Imperial College
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
DECEMBER 19, 2022
Treatment observably eased obsessive-compulsive disorder symptom severity in young patients, however, symptoms still caused students to be absent from school at least 2 days every month.
Fierce Healthcare
DECEMBER 19, 2022
COVID-19 vaccines protect against more than just COVID: study. fdiamond. Mon, 12/19/2022 - 12:03.
Pharmacy Times
DECEMBER 19, 2022
Specific immune checkpoint inhibitors added to frontline chemotherapy have transformed modern clinical practice.
Fierce Healthcare
DECEMBER 19, 2022
CDC: Bivalent vaccine cuts risk of COVID hospitalization by half. fdiamond. Mon, 12/19/2022 - 15:28.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
DECEMBER 19, 2022
Cariprazine (Vraylar; AbbVie, Gedeon Richter) is indicated as an adjunctive therapy to antidepressants for treating adult patients with major depressive disorder.
Fierce Pharma
DECEMBER 19, 2022
Novartis prunes nearly 300 jobs in Garden State as corporate slimdown rolls on. fkansteiner. Mon, 12/19/2022 - 10:53.
Pharmacy Times
DECEMBER 19, 2022
Atta Chowdhry, RPh, opens a discussion surrounding prophylactic treatment in patients diagnosed with hemophilia A.
Fierce Healthcare
DECEMBER 19, 2022
Former VA secretary's latest venture, Override, emerges out of stealth to tackle chronic pain. hlandi. Mon, 12/19/2022 - 07:59.
Pharmacy Times
DECEMBER 19, 2022
Tim Whitten, BSPharm, MBA, CEO & President of Taiho Oncology Inc discusses the critical impacts of pharmacists across the health care landscape.
Fierce Healthcare
DECEMBER 19, 2022
Epic plans to overhaul its app market, opens new 'connection hub' for developers. Here are key things to know. hlandi. Mon, 12/19/2022 - 11:56.
Pharmacy Times
DECEMBER 19, 2022
Identifying how survivors adjust to their cancer may help health care providers provide tailored self-management skills.
Pharmaceutical Technology
DECEMBER 19, 2022
Sanofi has extended the partnership with Innate Pharma for natural killer (NK) cell therapeutics in oncology. With the latest development, Sanofi will licence a NK cell engager programme that acts on B7H3 from the antibody-based NK cell engager therapeutics (ANKET) platform of Innate. Under the latest licence deal, Sanofi will make an upfront payment of $26.4m (€25m) to Innate.
Pharmacy Times
DECEMBER 19, 2022
The additional indication expands its therapeutic role beyond advanced non-small cell lung cancer.
STAT
DECEMBER 19, 2022
WASHINGTON — Leaders in Congress have reached a sweeping deal to ease Medicare pay cuts to doctors, make major changes to post-pandemic Medicaid policy, and to help prepare for future pandemics. Lawmakers are aiming to pass a health care policy package along with legislation to fund the federal government by Friday. The details of the omnibus spending package were confirmed by two lobbyists and two congressional aides.
Pharmacy Times
DECEMBER 19, 2022
Similar symptoms often make it difficult for patients to tell the contagious respiratory conditions apart.
STAT
DECEMBER 19, 2022
A bill that makes it easier for the Food and Drug Administration to withdraw drugs that were approved under an accelerated timeline also dropped provisions the industry had opposed, according to three drug lobbyists. The legislation was spurred by the fracas over the Alzheimer’s drug Aduhelm, which received a so-called accelerated approval. Nearly every member of an FDA advisory panel voted against approving the Biogen drug, though many advocates for patients with debilitating conditions
pharmaphorum
DECEMBER 19, 2022
Amicus Therapeutics could be just weeks away from getting EU approval for its new Pompe disease therapy Pombiliti after getting a positive opinion on the drug from the EMA’s human medicines committee. The CHMP said late last week it was recommending Pombiliti (cipaglucosidase alfa or ATB200) as an infused therapy for late-onset Pompe disease in adults given in combination with the enzyme stabiliser miglustat in a regimen known as AT-GAA.
STAT
DECEMBER 19, 2022
At first, Lena Harvey didn’t realize anything had changed. She just started doing strange, unexpected things: Cleaning her living room, for example, or playing with her puppy, a black schnauzer named Apollo. It hit her as she walked in from the patio one day. She looked at her husband, Anthony, and asked, “Honey, I haven’t been complaining about pain, have I?
Drug Store News
DECEMBER 19, 2022
Colleen Lindholz, president of Kroger Health, discusses the Food as Medicine platform and its mission to help people enjoy food so they can live healthier lives.
Let's personalize your content